metronidazole has been researched along with fosfomycin in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (20.00) | 18.7374 |
| 1990's | 4 (16.00) | 18.2507 |
| 2000's | 5 (20.00) | 29.6817 |
| 2010's | 8 (32.00) | 24.3611 |
| 2020's | 3 (12.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Bender, A; Czobor, P; Jelinek, B; Málnási-Csizmadia, A; Peragovics, Á; Simon, Z; Tombor, L; Végner, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Andåker, L; Burman, LG; Eklund, A; Graffner, H; Hansson, J; Hellberg, R; Höjer, H; Kjellgren, K; Kling, PA; Ljungqvist, U | 1 |
| Andersen, JC; Juul-Jensen, KE; Nøhr, M | 1 |
| Traub, WH | 1 |
| Andåker, L; Höjer, H; Kihlström, E; Lindhagen, J | 1 |
| Andåker, L; Höjer, H; Lindhagen, J | 1 |
| Lahnborg, G; Nord, CE | 1 |
| Hadziomerović, A; Lindhagen, J; Nordlung, S; Zbornik, J | 1 |
| Hoshino, E; Noda, T; Sato, T; Uematsu, H | 1 |
| Georgieff, M; Konrad, F; Neumeister, B; Rommel, H; Wagner, R | 1 |
| Apfalter, P; Blacky, A; Hirschl, AM; Makristathis, A; Rotter, ML; Willinger, B | 1 |
| Haga, K; Hiramatsu, K; Ishikawa, D; Kuwahara-Arai, K; Osada, T; Sasaki, T; Shibuya, T; Watanabe, S | 1 |
| Arpi, M; Fonnes, S; Gasbjerg, LS; Hallberg, HW; Holzknecht, BJ; Rosenberg, J; Weisser, JJ | 1 |
| Haga, K; Hiramatsu, K; Ishikawa, D; Ito, S; Kuwahara-Arai, K; Nagahara, A; Nakajima, A; Okahara, K; Osada, T; Sasaki, T; Shibuya, T; Takahashi, M; Watanabe, S | 1 |
| Arpi, M; Fonnes, S; Holzknecht, BJ; Rosenberg, J | 1 |
| Arpi, M; Fonnes, S; Holzknecht, BJ; Rosenberg, J; Weisser, JJ | 1 |
| Abouwarda, AM; Abu El-Wafa, WM; Faraag, AHI; Ismail, TA | 1 |
| Lin, Y; Miao, M; Shao, Y; Wang, B; Ye, G | 1 |
1 review(s) available for metronidazole and fosfomycin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
8 trial(s) available for metronidazole and fosfomycin
| Article | Year |
|---|---|
Fosfomycin/metronidazole compared with doxycycline/metronidazole for the prophylaxis of infection after elective colorectal surgery. A randomised double-blind multicentre trial in 517 patients.
Topics: Aged; Colon; Double-Blind Method; Doxycycline; Drug Therapy, Combination; Female; Fosfomycin; Humans; Male; Metronidazole; Middle Aged; Multicenter Studies as Topic; Postoperative Complications; Premedication; Rectum | 1992 |
Prophylactic single-dose fosfomycin and metronidazole compared with neomycin, bacitracin, metronidazole and ampicillin in elective colorectal operations.
Topics: Adult; Aged; Aged, 80 and over; Ampicillin; Bacitracin; Colorectal Neoplasms; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Fosfomycin; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Neomycin; Premedication; Prospective Studies; Randomized Controlled Trials as Topic; Surgical Wound Infection | 1990 |
Stratified duration of prophylactic antimicrobial treatment in emergency abdominal surgery. Metronidazole-fosfomycin vs. metronidazole-gentamicin in 381 patients.
Topics: Abdomen, Acute; Adolescent; Adult; Aged; Appendicitis; Cholecystitis; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fosfomycin; Gentamicins; Humans; Male; Metronidazole; Middle Aged; Peritonitis; Postoperative Complications; Random Allocation; Sepsis | 1987 |
Comparison of systemic prophylaxis with metronidazole/placebo and metronidazole/fosfomycin in colorectal surgery. A clinical study demonstrating the need for additional anti-aerobic prophylactic cover.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteria, Aerobic; Bacteriological Techniques; Clinical Trials as Topic; Colonic Diseases; Double-Blind Method; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Fosfomycin; Humans; Male; Metronidazole; Middle Aged; Placebos; Premedication; Random Allocation; Rectal Diseases; Sepsis; Surgical Wound Infection | 1984 |
Comparison of systemic prophylaxis with metronidazole-fosfomycin and metronidazole-cephalothin in elective colorectal surgery.
Topics: Anti-Bacterial Agents; Bacterial Infections; Bacteroides; Cephalothin; Clinical Trials as Topic; Colon; Colonic Diseases; Drug Therapy, Combination; Escherichia coli; Fosfomycin; Humans; Metronidazole; Microbial Sensitivity Tests; Postoperative Complications; Random Allocation; Rectal Diseases; Rectum; Sepsis | 1981 |
Changes in Intestinal Microbiota Following Combination Therapy with Fecal Microbial Transplantation and Antibiotics for Ulcerative Colitis.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Colitis, Ulcerative; Colon; Colonoscopy; Combined Modality Therapy; Drug Therapy, Combination; Dysbiosis; Fecal Microbiota Transplantation; Female; Fosfomycin; Gastrointestinal Microbiome; Humans; Male; Metronidazole; Middle Aged; Pilot Projects; Prospective Studies; Severity of Illness Index; Treatment Outcome; Young Adult | 2017 |
Intraperitoneal administration of fosfomycin, metronidazole, and granulocyte-macrophage colony-stimulating factor in patients undergoing appendectomy is safe: a phase II clinical trial.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Appendectomy; Fosfomycin; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Infusions, Parenteral; Laparoscopy; Length of Stay; Metronidazole; Middle Aged; Young Adult | 2019 |
The plasma pharmacokinetics of fosfomycin and metronidazole after intraperitoneal administration in patients undergoing appendectomy for uncomplicated appendicitis.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Appendectomy; Appendicitis; Denmark; Drug Combinations; Drug Monitoring; Fosfomycin; Humans; Laparoscopy; Male; Metronidazole; Middle Aged; Models, Biological; Postoperative Care; Prospective Studies; Surgical Wound Infection; Young Adult | 2020 |
16 other study(ies) available for metronidazole and fosfomycin
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Experimental confirmation of new drug-target interactions predicted by Drug Profile Matching.
Topics: Algorithms; Angiotensin-Converting Enzyme Inhibitors; Animals; CHO Cells; Cricetulus; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Humans; Molecular Conformation; Molecular Targeted Therapy; Peptidyl-Dipeptidase A; Receptors, Dopamine D1; Receptors, Dopamine D2; Structure-Activity Relationship; Substrate Specificity | 2013 |
Clostridium perfringens type A. Comparison of in vitro and in vivo activity of twelve antimicrobial drugs.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Clostridium perfringens; Fosfomycin; Gas Gangrene; Imipenem; Metronidazole; Mice; Microbial Sensitivity Tests; Oxacillin; Penicillin G; Thienamycins; Vancomycin | 1986 |
Efficacy of metronidazole and fosfomycin alone and in combination in the treatment of experimentally induced intra-abdominal infections.
Topics: Abdomen; Animals; Anti-Bacterial Agents; Bacterial Infections; Drug Therapy, Combination; Fosfomycin; Male; Metronidazole; Rats; Rats, Inbred Strains | 1984 |
In vitro antimicrobial susceptibility to combinations of drugs on bacteria from carious and endodontic lesions of human deciduous teeth.
Topics: Amoxicillin; Bacteria, Anaerobic; Cefaclor; Child; Child, Preschool; Ciprofloxacin; Dental Caries; Dental Pulp Diseases; Drug Therapy, Combination; Fosfomycin; Humans; Metronidazole; Microbial Sensitivity Tests; Miocamycin; Tooth, Deciduous | 1993 |
Studies on drug monitoring in thrice and once daily treatment with aminoglycosides.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cefotaxime; Cross Infection; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fosfomycin; Gram-Negative Bacterial Infections; Humans; Infusions, Intravenous; Intensive Care Units; Male; Metabolic Clearance Rate; Metronidazole; Middle Aged; Netilmicin; Piperacillin; Respiration, Artificial; Staphylococcal Infections; Teicoplanin | 1993 |
In vitro activity of fosfomycin alone and in combination with amoxicillin, clarithromycin and metronidazole against Helicobacter pylori compared with combined clarithromycin and metronidazole.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Fosfomycin; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests | 2005 |
The Combination of Fosfomycin, Metronidazole, and Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor is Stable in vitro and Has Maintained Antibacterial Activity.
Topics: Anti-Bacterial Agents; Drug Combinations; Drug Stability; Fosfomycin; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Metronidazole; Microbial Sensitivity Tests; Recombinant Proteins | 2018 |
The Microbial Composition of Bacteroidetes Species in Ulcerative Colitis Is Effectively Improved by Combination Therapy With Fecal Microbiota Transplantation and Antibiotics.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacteroidetes; Colitis, Ulcerative; Combined Modality Therapy; Dysbiosis; Fecal Microbiota Transplantation; Feces; Fosfomycin; Gastrointestinal Microbiome; Humans; Metronidazole; Remission Induction; Treatment Outcome | 2018 |
Synergistic activity and molecular modelling of fosfomycin combinations with some antibiotics against multidrug resistant Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Doxycycline; Fosfomycin; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Rifampin | 2022 |
Antibiotic resistance status of helicobacter pylori strains isolated from initial eradication patients in Ningbo, China, from 2017 to 2021.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Doxycycline; Drug Resistance, Bacterial; Fosfomycin; Furazolidone; Gatifloxacin; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ornidazole; Rifampin; Tinidazole | 2022 |